Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) Institutional Ownership

CUSIP: 83548R204

13F Institutional Holders and Ownership History from Q3 2022 to Q4 2023

Type / Class
Equity / COM NEW
Symbol
SONN on Nasdaq
Shares outstanding
6,190,476
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Republic Digital Opportunistic Digital Assets Master Fund, Ltd. 4.2% 260,000 Republic Digital Opportunistic Digital Assets Master Fund, Ltd. 14 Jul 2025

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$28 0
2023 Q3 142 $28 -$2,106,519 $0.20 1
2023 Q2 4,300,953 $2,106,589 -$696,648 $0.49 23
2023 Q1 7,307,337 $2,631,129 +$2,543,749 $0.36 17
2022 Q4 130,890 $150,867 -$152,126 $1.15 13
2022 Q3 255,601 $376,000 +$376,000 $1.47 7